Islam Imadul, Brown Greg, Bryant Judi, Hrvatin Paul, Kochanny Monica J, Phillips Gary B, Yuan Shendong, Adler Marc, Whitlow Marc, Lentz Dao, Polokoff Mark A, Wu James, Shen Jun, Walters Janette, Ho Elena, Subramanyam Babu, Zhu Daguang, Feldman Richard I, Arnaiz Damian O
Berlex Biosciences, 2600 Hilltop Dr. Richmond, CA 94804, USA.
Bioorg Med Chem Lett. 2007 Jul 15;17(14):3819-25. doi: 10.1016/j.bmcl.2007.05.060. Epub 2007 May 23.
Based on the lead compound BX-517, a series of C-4' substituted indolinones have been synthesized and evaluated for PDK1 inhibition. Modification at C-4' of the pyrrole afforded potent compounds (7b and 7d) with improved solubility and ADME properties. In this letter, we describe the synthesis, selectivity profile, and pharmacokinetic data of selected compounds.
基于先导化合物BX-517,已合成了一系列C-4'取代的吲哚啉酮,并对其进行了PDK1抑制活性评估。吡咯C-4'位的修饰产生了具有改善的溶解性和ADME性质的强效化合物(7b和7d)。在本信函中,我们描述了所选化合物的合成、选择性概况和药代动力学数据。